|
|
|
|
|
|
|
|
|
|
Hinweise |
|
|
Wiss. Komitee |
|
|
Adressen |
|
|
Presse |
|
|
Öffnungszeiten |
|
|
Gesellschaften |
|
|
Hotelreservierung |
|
|
Termine |
|
|
Rahmenprogramm |
|
|
Gebühren |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Online-Anmeldung
Online-Abstracts
Kontakt-Adressen
Congress Center Leipzig
zurück zum Start
Programm-Schwerpunkte-Gesellschaften
Symposium 24 Antiinfektiva II – neue Chinolone |
||
15.45 - 17.15 |
Vorsitz Dr. U. Wintergerst; München, P. Heisig; Hamburg |
|
Level 1 – Raum 4 |
|
|
04.05.2001 |
Sy 24.01 |
Stellenwert neuer Fluorchinolone – eine Übersicht |
12.00 |
H.J. Linde; Regensburg |
|
Sy 24.02 |
Stärken und Schwächen neuer Fluorchinolone – aus mikrobiologischer Sicht |
|
12.25 |
F.J. Schmitz; Düsseldorf |
|
Sy 24.03 |
Toxikologisches Profil von Chinolonen |
|
12.50 |
Dr. U. Wintergerst |
|
Sy 24.04 |
Bedeutung neuer Fluorchinolone in der Intensivmedizin |
|
13.15 |
W.V. Kern; Ulm |
|
Sy 24.05 |
Neue Fluorchinolone im ambulanten Bereich – die „neuen Penicilline“? |
|
13.40 |
F. Vogel; Hofheim |
|
Mit freundlicher Unterstützung durch Bayer Vital |